North America Dental Bone Graft Substitute and Barrier Membrane Market

The North America dental bone graft substitute and barrier membrane market is expected to grow from US$ 293.65 million in 2022 to US$ 552.38 million by 2030. It is estimated to grow at a CAGR of 8.2% from 2022 to 2030.   

Strategic Developments by Market Players Fuel North America Dental Bone Graft Substitute and Barrier Membrane Market

Development strategies such as product launches, mergers and acquisitions, and expansions boost the growth of the North America Dental Bone Graft Substitute and Barrier Membrane Market. In April 2023, ZimVie announced the launch of RegenerOss CC Allograft Particulate and RegenerOss Bone Graft Plug, which helped it extend its portfolio of biomaterials that are intended for filling extraction sockets and periodontal defects. The products are commercially available in North America. In May 2023, Straumann acquired GalvoSurge Dental AG, a Swiss medical device manufacturer. The acquired company specializes in implant care and maintenance solutions to support the treatment of peri-implantitis. In October 2022, Geistlich, specialized in the regeneration of bone, cartilage, and tissue, acquired Lynch Biologics, US. The acquisition helped Geistlich Pharma to strengthen its portfolio by adding Lynch Biologics, LLC's leading GEM 21S product to it. GEM 21S is based on a growth factor that accelerates bone formation and wound healing. The companies further aim to innovate regenerative technologies in dentistry. In December 2022, Neoss Group, which designs, manufactures, and sells dental implant treatment products, opened a new sales office in the Nordic region. The facility commenced operations in the Nordic region on December 01, 2022, to support dental professionals and their patients. In January 2021, Dentsply Sirona acquired Datum Dental, a leading provider of innovative OSSIX regenerative solutions. The acquisition enabled Dentsply Sirona to acquire the strong OSSIX biomaterial portfolio of Datum Dental, Ltd. It also offered it access to the patented GLYMATRIX technology of Datum Dental Ltd. GLYMATRIX mimics the natural collagen cycle in the body, i.e., a biochemical process called glycation. GLYMATRIX forms the basis of OSSIX products for guided bone regeneration, as well as guided tissue regeneration.

North America Dental Bone Graft Substitute and Barrier Membrane Market Overview

The North America North America dental bone graft substitute and barrier membrane market is segmented into the US, Canada, and Mexico. The US is expected to account for the largest share of the North America Dental Bone Graft Substitute and Barrier Membrane Market. The growth of the market in the US is attributed to the rise in the prevalence of dental diseases across the country, regular dental check-ups, and technological improvements. 

North America Dental Bone Graft Substitute and Barrier Membrane Market Revenue and Forecast to 2030 (US$ Million)

North America Dental Bone Graft Substitute and Barrier Membrane Strategic Insights

Strategic insights for the North America Dental Bone Graft Substitute and Barrier Membrane provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

North America Dental Bone Graft Substitute and Barrier Membrane Report Scope

North America Dental Bone Graft Substitute and Barrier Membrane Regional Insights

The geographic scope of the North America Dental Bone Graft Substitute and Barrier Membrane refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

North America Dental Bone Graft Substitute and Barrier Membrane Market Segmentation

The North America dental bone graft substitute and barrier membrane market is segmented into product, procedures, end user and country.

Based on product, the North America dental bone graft substitute and barrier membrane market is bifurcated into dental bone graft substitutes and dental barrier membranes. The dental bone graft substitutes segment held a larger share of the North America dental bone graft substitute and barrier membrane market in 2022.

Based on procedures, the North America dental bone graft substitute and barrier membrane market is segmented into guided bone regeneration (GBR) procedures, guided tissue regeneration (GTR) procedures, sinus-lift and ridge-split procedures, alveolar ridge preservation (ARP), block-graft procedures, periodontal regeneration procedures, socket preservation, and others. The sinus-lift and ridge-split segment held the largest share of the North America dental bone graft substitute and barrier membrane market in 2022.

Based on end user, the North America dental bone graft substitute and barrier membrane market is segmented into hospitals, dental clinics, and others. The dental clinics segment held the largest share of the North America dental bone graft substitute and barrier membrane market in 2022.

Based on country, the North America dental bone graft substitute and barrier membrane market is segmented into the US, Canada, and Mexico. The US dominated the North America dental bone graft substitute and barrier membrane market in 2022.

Geistlich Pharma AG, Medtronic Plc, Dentsply Sirona Inc, ZimVie Inc, Regenity Biosciences Inc, Neoss UK & Ireland Ltd, Institut Straumann AG, and Resorba Medical GmbH are the leading companies operating in the North America dental bone graft substitute and barrier membrane market.